These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31549241)

  • 21. Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients.
    Gemignani L; Savarino V; Ghio M; Parodi A; Zentilin P; de Bortoli N; Negrini S; Furnari M; Dulbecco P; Giambruno E; Savarino E
    Semin Arthritis Rheum; 2013 Apr; 42(5):522-9. PubMed ID: 23352249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms and esophageal motility based on phenotypic findings of scleroderma.
    Tang DM; Pathikonda M; Harrison M; Fisher RS; Friedenberg FK; Parkman HP
    Dis Esophagus; 2013; 26(2):197-203. PubMed ID: 22590983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-phase radionuclide esophageal transit in progressive systemic sclerosis.
    Wang SJ; Lan JL; Chen DY; Chen YH; Hsieh TY; Kao CH; Lin WY
    Hepatogastroenterology; 2002; 49(46):989-91. PubMed ID: 12143260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma].
    Wehrmann T; Caspary WF
    Klin Wochenschr; 1990 Jun; 68(12):602-7. PubMed ID: 2198381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal manometry in systemic sclerosis: screening procedure or confined to symptomatic patients?
    Lock G; Zeuner M; Straub RH; Hein R; Lang B; Schölmerich J; Holstege A
    Rheumatol Int; 1997; 17(2):61-6. PubMed ID: 9266622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative esophageal and anorectal motility in scleroderma.
    Hamel-Roy J; Devroede G; Arhan P; Tétreault L; Duranceau A; Ménard HA
    Gastroenterology; 1985 Jan; 88(1 Pt 1):1-7. PubMed ID: 3964758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement.
    Gonzalez R; Storr M; Bloching H; Seige M; Ott R; Allescher HD
    J Clin Gastroenterol; 2001 Feb; 32(2):123-7. PubMed ID: 11205646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oesophageal manometry and video-radiology in patients with systemic sclerosis: a retrospective study of its clinical value.
    Ipsen P; Egekvist H; Aksglaede K; Zachariae H; Bjerring P; Thommesen P
    Acta Derm Venereol; 2000; 80(2):130-3. PubMed ID: 10877135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Roentgenkymography in esophageal dyskinesia in scleroderma].
    BASSI G; LURA A
    Radioter Radiobiol Fis Medica; 1951; 6():1-24. PubMed ID: 14912387
    [No Abstract]   [Full Text] [Related]  

  • 30. Esophageal motor disturbances in progressive systemic sclerosis.
    Henry MA; Harbermann MC; Rocha OM
    Dis Esophagus; 1999; 12(1):51-3. PubMed ID: 10941862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metoclopramide response in patients with early diffuse systemic sclerosis. Effects on esophageal motility abnormalities.
    Mercado U; Arroyo de Anda R; Avendaño L; Araiza-Casillas R; Avendaño-Reyes M
    Clin Exp Rheumatol; 2005; 23(5):685-8. PubMed ID: 16173247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis.
    Lock G; Straub RH; Zeuner M; Antoniou E; Holstege A; Schölmerich J; Lang B
    J Rheumatol; 1998 Jul; 25(7):1330-5. PubMed ID: 9676765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ineffective esophageal motility].
    Leandri C; Guillaumot MA; Dohan A; Leconte M; Coriat R; Chaussade S; Barret M
    Presse Med; 2019 Sep; 48(9):897-903. PubMed ID: 31471090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of oesophageal motility abnormalities.
    Spechler SJ; Castell DO
    Gut; 2001 Jul; 49(1):145-51. PubMed ID: 11413123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of endoscopic ultrasonography in esophageal motility disorders.
    Ziegler K; Zimmer T
    Endoscopy; 1992 May; 24 Suppl 1():338-41. PubMed ID: 1633777
    [No Abstract]   [Full Text] [Related]  

  • 37. [Correlation between the radiologic study of deglutition and the clinical picture in systemic sclerosis (scleroderma)].
    Montesi A; Pesaresi A; Cavalli ML; Serri L; Salmistraro D; Candela M; Gabrielli A
    Radiol Med; 1990 Sep; 80(3):296-300. PubMed ID: 2236689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal motility and pulmonary function in progressive systemic sclerosis.
    Denis P; Ducrotte P; Pasquis P; Lefrançois R
    Respiration; 1981; 42(1):21-4. PubMed ID: 7330460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal involvement in mixed connective tissue disease.
    Doria A; Bonavina L; Anselmino M; Ruffatti A; Favaretto M; Gambari P; Peracchia A; Todesco S
    J Rheumatol; 1991 May; 18(5):685-90. PubMed ID: 1865414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed Tomography of the Esophagus in Scleroderma and Lung Disease.
    Takekoshi D; Arami S; Sheppard TJ; Cole-Saffold P; Michel JC; Kondos GT; Schraufnagel DE
    Tohoku J Exp Med; 2015 Dec; 237(4):345-52. PubMed ID: 26639310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.